Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases.
Kilian G M BrownNabila AnsariMichael J SolomonKirk K S AustinAuerilius E R HamiltonChristopher John YoungPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2020)
Early results from this initial experience with simultaneous PE, CRS and HIPEC suggest that this combined procedure is safe and feasible; however, the long-term oncological and quality of life outcomes require further investigation.